Esperion Therapeutics, Inc. (NASDAQ:ESPR)’s Basic Consolidated EPS Came In At $-2.2609

0

Esperion Therapeutics, Inc. (NASDAQ:ESPR) posted annual consolidated EPS of $-2.2609 for the period ended 2015-12-31. But basic consolidated EPS for the quarter period ended 2015-12-31 came in at $-2.2609.

Basic EPS from continuing operations

The company’s basic EPS from continuing operations for the annual period ended 2015-12-31 came in at $-2.2609 while basic EPS from continuing operations for the three-month period to 2015-12-31 was$-2.2609.

EPS contribution from parent

Esperion Therapeutics, Inc. (NASDAQ:ESPR) received $-2.2609 basic EPS contribution from its parent company in the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, the parent company contributed EPS of $-2.2609.

Basic net EPS

Esperion Therapeutics, Inc. (NASDAQ:ESPR) posted basic net EPS of $-2.26 for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, the company posted basic net EPS of $-2.26.

Consolidated diluted EPS

The company’s consolidated diluted EPS for the period ended 2015-12-31 was $-2.2609 while consolidated diluted EPS was $-2.2609 for the quarter ended 2015-12-31.

Basic diluted EPS

Basic diluted EPS from continuing operation for the annual period ended 2015-12-31 was $-2.2609. As for the quarter, diluted EPS from continuing operations for the three-month ended 2015-12-31 stood at $-2.2609.

Net diluted EPS

Net diluted EPS was $-2.26 for the annual period ended 2015-12-31. But net diluted EPS for the quarterly period ended 2015-12-31 stood at $-2.26.

Diluted EPS from parent

From the parent company, Esperion Therapeutics, Inc. (NASDAQ:ESPR) received diluted EPS of $-2.2609

For the annual period ended 2015-12-31, diluted EPS from Esperion Therapeutics, Inc. (NASDAQ:ESPR)’s parent company was$-2.2609. But for the quarter period ended 2015-12-31, diluted EPS contribution from the parent company was $-2.2609.

Esperion Therapeutics, Inc. (NASDAQ:ESPR)’s net basic EPS for the annual period ended 2015-12-31 was $-2.26 and for the quarter period ended 2015-12-31 it was $-2.26.

For the annual period ended 2015-12-31, the company had average basic shares outstanding of 22.02 while basic shares outstanding were 22.02 for the quarter period ended 2015-12-31.

The company’s diluted shares outstanding was 22.02 for the annual period ended 2015-12-31 is 22.02. That compared with 22.02 diluted shares outstanding for the quarter period ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 9 times, 1 visits today)